EAM Investors, LLC - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 133 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q3 2014. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.

Quarter-by-quarter ownership
EAM Investors, LLC ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2015$4,333,000
-2.0%
350,410
-5.8%
0.51%
-0.8%
Q1 2015$4,420,000
-5.1%
372,015
-9.8%
0.51%
-21.4%
Q4 2014$4,658,000
+94.4%
412,233
+51.1%
0.65%
+33.5%
Q3 2014$2,396,000
+177.6%
272,905
+130.7%
0.49%
+197.0%
Q2 2014$863,000118,3130.16%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q3 2014
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 514,853$2,595,0002.23%
GARRISON BRADFORD & ASSOCIATES INC 98,001$494,0000.48%
Catalyst Capital Advisors LLC 380,896$1,920,0000.44%
Knoll Capital Management, LLC 160,585$809,0000.42%
Tekla Capital Management LLC 757,050$3,816,0000.38%
FULLER & THALER ASSET MANAGEMENT, INC. 524,800$2,645,0000.13%
Integre Asset Management, LLC 103,493$522,0000.12%
CAMBRIDGE TRUST CO 220,003$1,109,0000.10%
JAMISON EATON & WOOD INC /NJ 62,782$316,0000.09%
STONERIDGE INVESTMENT PARTNERS LLC 88,304$445,0000.09%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders